Table 3 Relative expression levels of RBM6 in chimeric positive versus chimeric negative tumour samples compared to non-tumour
From: RBM6-RBM5 transcription-induced chimeras are differentially expressed in tumours
|  | RBM6 (mean ± SD) | Control (S28) (mean ± SD) | normalized RBM6 | fold change in tumour compared to non-tumour |
|---|---|---|---|---|
Breast Tissue | Â | Â | Â | Â |
tumour | Â | Â | Â | Â |
   chimeric transcript (+) | 0.403 ± 0.008 | 0.073 ± 0.007 | 5.521 | 24.43 |
   chimeric transcript (-) | 0.243 ± 0.012 | 0.066 ± 0.01 | 3.682 | 16.3 |
non-tumour | 0.051 ± 0.006 | 0.226 ± 0.06 | 0.226 | 1 |
Skeletal Muscle | Â | Â | Â | Â |
tumour: chimeric transcript (+) | 0.0488 ± 0.001 | 0.0489 ± 0.005 | 0.998 | 14.06 |
non-tumour | 0.005 ± 0.0003 | 0.070 ± 0.01 | 0.071 | 1 |
tumour: chimeric transcript (-) | 0.063 ± 0.01 | 0.297 ± 0.058 | 0.212 | 1.52 |
non-tumour | 0.022 ± 0.002 | 0.158 ± 0.02 | 0.139 | 1 |